We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VBLT market cap is 1.4M. The company's latest EPS is USD -1.2514 and P/E is -0.55.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 310k | 1,000 |
| Operating Income | -3.3M | -676k | -812k | -9.87M | -3.84M |
| Net Income | -2.64M | -874k | -1.07M | -6.68M | -3.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 562k | 922k | 768k | 658k | 310k |
| Operating Income | -20.01M | -24.48M | -30M | -32.85M | -14.66M |
| Net Income | -19.46M | -24.23M | -29.92M | -32.3M | -11.26M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.11M | 24.65M | 20.94M | 19.54M | 15.6M |
| Total Liabilities | 8.21M | 5.41M | 2.6M | 4.43M | 4.05M |
| Total Equity | 19.9M | 19.24M | 18.34M | 15.11M | 11.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.62M | 41.71M | 64.66M | 29.66M | 19.54M |
| Total Liabilities | 12.78M | 10.79M | 12.48M | 7.21M | 4.43M |
| Total Equity | 35.84M | 30.92M | 50.58M | 22.45M | 15.11M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.69M | -4.05M | -7.64M | -13.72M | -3.56M |
| Investing | 10.1M | 10.29M | 10.45M | 15.54M | -6k |
| Financing | N/A | 1,000 | 1,000 | 7.82M | -19k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.7M | -23.38M | -24.98M | -31.59M | -13.72M |
| Investing | -6.6M | 9.89M | -15.49M | 27.3M | 15.54M |
| Financing | -757k | 17.07M | 49.11M | 22k | 7.82M |
| Market Cap | 1.4M |
| Price to Earnings Ratio | -0.55 |
| Price to Sales Ratio | 20.06 |
| Price to Cash Ratio | 0.53 |
| Price to Book Ratio | 0.41 |
| Dividend Yield | - |
| Shares Outstanding | 9M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -98.34% |
| 52 Week High | 11.20 |
| 52 Week Low | 5.341 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Vascular Biogenics Ltd |
| Address |
8 hasatat st modi'in-maccabim-re'ut, center 7178106 |
| Website | https://www.vblrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
